Monitoring and comorbidities in patients with chronic hepatitis B currently treated with nucleos(t)ide analogs

BACKGROUND: Long-term monotherapy with nucleos(t)ide analogs (NAs) represents the treatment option for the majority of patients with chronic hepatitis B (CHB), an aging population with a greater likelihood of comorbidities. We assessed the prevalence of concurrent non-hepatic diseases and the safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Siakavellas, Spyros, Goulis, John, Manolakopoulos, Spilios, Triantos, Christos, Gatselis, Nikolaos, Tsentemidou, Eva, Kranidioti, Hariklia, Ζisimopoulos, Κonstantinos, Τsoulas, Christos, Dalekos, George, Papatheodoridis, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774663/
https://www.ncbi.nlm.nih.gov/pubmed/33414625
http://dx.doi.org/10.20524/aog.2020.0525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774663/
https://www.ncbi.nlm.nih.gov/pubmed/33414625
http://dx.doi.org/10.20524/aog.2020.0525

Ejemplares similares